APA (7th ed.) Citation

Henter, I. D., Park, L. T., & Zarate, C. A. (2021). Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status. CNS drugs, 35(5), 527-543. https://doi.org/10.1007/s40263-021-00816-x

Chicago Style (17th ed.) Citation

Henter, Ioline D., Lawrence T. Park, and Carlos A. Zarate. "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status." CNS Drugs 35, no. 5 (2021): 527-543. https://doi.org/10.1007/s40263-021-00816-x.

MLA (9th ed.) Citation

Henter, Ioline D., et al. "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status." CNS Drugs, vol. 35, no. 5, 2021, pp. 527-543, https://doi.org/10.1007/s40263-021-00816-x.